Evolent Health
EVH
234 hedge funds and large institutions have $4.2B invested in Evolent Health in 2023 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 92 increasing their positions, 65 reducing their positions, and 19 closing their positions.
168% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 19
42% more repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 65
26% more capital invested
Capital invested by funds: $3.34B → $4.2B (+$854M)
15% more funds holding
Funds holding: 203 → 234 (+31)
2.6% more ownership
Funds ownership: 107.91% → 110.51% (+2.6%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
38% less call options, than puts
Call options by funds: $12.1M | Put options by funds: $19.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$115M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$33.9M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
+$32.7M |
| 4 |
BlackRock
New York
|
+$16.6M |
| 5 |
Morgan Stanley
New York
|
+$15.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$102M |
| 2 |
GF
Greenhouse Funds
Baltimore,
Maryland
|
-$38.3M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$36.8M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$25M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$10.4M |
EVH Hedge Fund Activity: Q4 2023 in Review
234 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q4 2023, worth a combined $4.2B — up 26% from $3.34B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new EVH positions and 19 closed out — a net gain of 32 holders — while 92 added to existing stakes and 65 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $115M. The largest seller was Fidelity Investments, cutting an estimated $102M.
- 234 institutional investors held Evolent Health (EVH) as of Q4 2023, up from 203 in Q3 2023.
- Funds reported $4.2B of Evolent Health stock for Q4 2023, up 26% quarter-over-quarter.
- 51 funds opened new Evolent Health positions in Q4 2023 and 19 closed out, a net change of +32 holders.
- The largest Evolent Health buyer in Q4 2023 was Wellington Management Group, an estimated $115M added.
- The largest Evolent Health seller in Q4 2023 was Fidelity Investments, an estimated $102M sold.
Based on aggregated 13F filings for Q4 2023.